DOI: 10.12890/2020_001526

Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone

Authors

  • Radovan Hojs
  • Tadej Pedreski Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
  • Nejc Piko Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
  • Matevž Privšek Centre for Emergency Medicine, University Medical Centre Maribor, Maribor, Slovenia
  • Tadej Zorman Centre for Emergency Medicine, University Medical Centre Maribor, Maribor, Slovenia
  • Sebastjan Bevc Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia

tadej.petreski@ukc-mb.si

Keywords

Amiodarone, adverse drug reaction, hyperthyroidism, atrial fibrillation, skin pigmentation

Abstract

Amiodarone is an antiarrhythmic drug, in use from the 1960s, which acts on potassium transport in myocytes, causing a lengthening of the action potential and refractory period. Even though it is broadly prescribed, its use is limited by a relatively high occurrence of adverse reactions such as lung, thyroid or hepatic disease, skin changes and so on. The authors report a case of a female patient who was admitted due to chest pain. Due to the bluish skin pigmentation, other causes of amiodarone toxicity were investigated, and hyperthyroidism was detected. After amiodarone discontinuation and specific therapy, thyroid function returned to normal.

View the entire article

Downloads

Published

2020-03-03

Issue

Vol. 7 No. 4 (2020)

How to Cite

1.
Hojs R, Pedreski T, Piko N, Privšek M, Zorman T, Bevc S. Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone. EJCRIM [Internet]. 2020 Mar. 3 [cited 2026 Nov. 3];7(4). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1526

Most read articles by the same author(s)